This episode touches on Federal Prosecution for cannabis related charges, the process of licensing, and how she entered the cannabis industry.
STAY TUNED FOR NEW EPISODES OF 411/420. THURSDAYS, EXCLUSIVELY ON CASHCROPTODAY.COM
Connect with CashCropToday
Find us on Facebook: https://www.facebook.com/cashcroptoday
Follow us on Twitter: https://twitter.com/cashcroptoday
Follow us on Instagram: https://www.instagram.com/cashcroptoday
You may be interested
Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Editor - November 27, 2018Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…
Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Editor - November 26, 2018Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…
GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Editor - November 26, 2018GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…
Most from this category
420 Real Properties: Cultivation, Manufacturing & Distribution Facility For Sale
Ricky M - November 21, 2018
Providence Brands and Lost Craft Beer to Partner on Cannabis Infused Beer Brand
Editor - November 20, 2018
OUR PICKS
Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Editor - November 27, 2018Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…
Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Editor - November 26, 2018Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…
GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Editor - November 26, 2018GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…
MOST POPULAR
